Search

Robert A. Wax

Supervisory Patent Examiner (ID: 262, Phone: (571)272-0623 , Office: P/1615 )

Most Active Art Unit
1615
Art Unit(s)
1805, 1105, 1656, 1506, 1507, 1814, 1652, 1615, 1807, 1653, 1808
Total Applications
1637
Issued Applications
935
Pending Applications
421
Abandoned Applications
282

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6361199 [patent_doc_number] => 20020058621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Method for induced lactation' [patent_app_type] => new [patent_app_number] => 09/910473 [patent_app_country] => US [patent_app_date] => 2001-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5605 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058621.pdf [firstpage_image] =>[orig_patent_app_number] => 09910473 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/910473
Method for induced lactation Jul 19, 2001 Issued
Array ( [id] => 7361640 [patent_doc_number] => 20040014654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Method for treating unstable angina pectoris' [patent_app_type] => new [patent_app_number] => 10/333212 [patent_app_country] => US [patent_app_date] => 2003-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3941 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014654.pdf [firstpage_image] =>[orig_patent_app_number] => 10333212 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/333212
Method for treating unstable angina pectoris Jul 19, 2001 Issued
Array ( [id] => 1037556 [patent_doc_number] => 06872705 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-29 [patent_title] => 'Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions' [patent_app_type] => utility [patent_app_number] => 09/904753 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5823 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/872/06872705.pdf [firstpage_image] =>[orig_patent_app_number] => 09904753 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/904753
Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions Jul 12, 2001 Issued
Array ( [id] => 5936604 [patent_doc_number] => 20020061852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Methods of therapy with thrombin derived peptides' [patent_app_type] => new [patent_app_number] => 09/904090 [patent_app_country] => US [patent_app_date] => 2001-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5353 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061852.pdf [firstpage_image] =>[orig_patent_app_number] => 09904090 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/904090
Methods of therapy with thrombin derived peptides Jul 11, 2001 Issued
Array ( [id] => 1086074 [patent_doc_number] => 06831151 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-12-14 [patent_title] => 'Mast cell-specific signal transducing molecules and cDNAs thereof' [patent_app_type] => B1 [patent_app_number] => 09/856061 [patent_app_country] => US [patent_app_date] => 2001-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 6432 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/831/06831151.pdf [firstpage_image] =>[orig_patent_app_number] => 09856061 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/856061
Mast cell-specific signal transducing molecules and cDNAs thereof Jul 9, 2001 Issued
09/786797 Human cytoskeleton associated proteins Jun 24, 2001 Abandoned
Array ( [id] => 7607403 [patent_doc_number] => 07098313 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-29 [patent_title] => 'DNA sequences coding for a polyol carrier and their use, in particular for the preparation of transgenic plants' [patent_app_type] => utility [patent_app_number] => 10/332815 [patent_app_country] => US [patent_app_date] => 2001-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9151 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/098/07098313.pdf [firstpage_image] =>[orig_patent_app_number] => 10332815 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/332815
DNA sequences coding for a polyol carrier and their use, in particular for the preparation of transgenic plants Jun 21, 2001 Issued
Array ( [id] => 6801576 [patent_doc_number] => 20030096741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Enhanced mineral delivery' [patent_app_type] => new [patent_app_number] => 09/885593 [patent_app_country] => US [patent_app_date] => 2001-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4286 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096741.pdf [firstpage_image] =>[orig_patent_app_number] => 09885593 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/885593
Enhanced mineral delivery Jun 18, 2001 Abandoned
Array ( [id] => 1080944 [patent_doc_number] => 06835813 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-12-28 [patent_title] => 'Testis-specific differentiation-regulatory factor' [patent_app_type] => B1 [patent_app_number] => 09/743237 [patent_app_country] => US [patent_app_date] => 2001-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10080 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/835/06835813.pdf [firstpage_image] =>[orig_patent_app_number] => 09743237 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/743237
Testis-specific differentiation-regulatory factor Jun 3, 2001 Issued
Array ( [id] => 1115463 [patent_doc_number] => 06800492 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-10-05 [patent_title] => 'Chimeric GFP-aequorin as bioluminescent Ca reporters at the single cell level' [patent_app_type] => B2 [patent_app_number] => 09/863901 [patent_app_country] => US [patent_app_date] => 2001-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 24901 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/800/06800492.pdf [firstpage_image] =>[orig_patent_app_number] => 09863901 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/863901
Chimeric GFP-aequorin as bioluminescent Ca reporters at the single cell level May 23, 2001 Issued
09/763919 Pharmaceutical compositions comprising factor xillla May 20, 2001 Abandoned
Array ( [id] => 6559497 [patent_doc_number] => 20020164640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'MyD88 adapter-like proteins' [patent_app_type] => new [patent_app_number] => 09/860696 [patent_app_country] => US [patent_app_date] => 2001-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15602 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164640.pdf [firstpage_image] =>[orig_patent_app_number] => 09860696 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/860696
MyD88 adapter-like proteins May 16, 2001 Issued
09/701787 Peptides having nuclear transport activity May 10, 2001 Abandoned
Array ( [id] => 6638958 [patent_doc_number] => 20030211993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Method for promoting neovascularization' [patent_app_type] => new [patent_app_number] => 10/275997 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10877 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211993.pdf [firstpage_image] =>[orig_patent_app_number] => 10275997 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/275997
Method for promoting neovascularization May 6, 2001 Issued
Array ( [id] => 1024736 [patent_doc_number] => 06884778 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-26 [patent_title] => 'Biocompatible macromers' [patent_app_type] => utility [patent_app_number] => 09/845570 [patent_app_country] => US [patent_app_date] => 2001-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8877 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/884/06884778.pdf [firstpage_image] =>[orig_patent_app_number] => 09845570 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/845570
Biocompatible macromers Apr 29, 2001 Issued
Array ( [id] => 6406185 [patent_doc_number] => 20020182668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Human PEG3 gene and uses thereof' [patent_app_type] => new [patent_app_number] => 09/842777 [patent_app_country] => US [patent_app_date] => 2001-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8154 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20020182668.pdf [firstpage_image] =>[orig_patent_app_number] => 09842777 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/842777
Human PEG3 gene and uses thereof Apr 26, 2001 Abandoned
09/830244 LYSINE-RICH STATHERIN PROTEIN Apr 22, 2001 Abandoned
Array ( [id] => 985627 [patent_doc_number] => 06924357 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-02 [patent_title] => 'Lipid binding protein 4' [patent_app_type] => utility [patent_app_number] => 10/257637 [patent_app_country] => US [patent_app_date] => 2001-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9739 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/924/06924357.pdf [firstpage_image] =>[orig_patent_app_number] => 10257637 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/257637
Lipid binding protein 4 Apr 10, 2001 Issued
Array ( [id] => 6792713 [patent_doc_number] => 20030088057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'PEPTIDE SUBSTRATES PHOSPHORYLATED BY P21-ACTIVAGED PROTEIN KINASE STATEMENT REGARDING FEDERALLY SPONSORED REASEARCH OR DEVELOPMENT' [patent_app_type] => new [patent_app_number] => 09/827542 [patent_app_country] => US [patent_app_date] => 2001-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8720 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20030088057.pdf [firstpage_image] =>[orig_patent_app_number] => 09827542 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/827542
PEPTIDE SUBSTRATES PHOSPHORYLATED BY P21-ACTIVAGED PROTEIN KINASE STATEMENT REGARDING FEDERALLY SPONSORED REASEARCH OR DEVELOPMENT Apr 5, 2001 Abandoned
Array ( [id] => 6683127 [patent_doc_number] => 20030118991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Ataxia-telangiectasia gene and its genomic organization' [patent_app_type] => new [patent_app_number] => 09/825476 [patent_app_country] => US [patent_app_date] => 2001-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22652 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20030118991.pdf [firstpage_image] =>[orig_patent_app_number] => 09825476 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/825476
Ataxia-telangiectasia gene and its genomic organization Apr 2, 2001 Abandoned
Menu